Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

REGN

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REGN
DateTimeSourceHeadlineSymbolCompany
30/09/202006:58Dow Jones NewsRegeneron Drug Found to Help Treat Covid-19 in Early Disease StageNASDAQ:REGNRegeneron Pharmaceuticals Inc
30/09/202006:01PR Newswire (US)Regeneron's REGN-COV2 Antibody Cocktail Reduced Viral Levels and Improved Symptoms in Non-Hospitalized COVID-19 PatientsNASDAQ:REGNRegeneron Pharmaceuticals Inc
24/09/202006:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
24/09/202006:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
21/09/202022:25PR Newswire (US)Late-breaking ESMO Presentation Shows Libtayo® (cemiplimab) Monotherapy Increases Overall Survival in First-line Advanced No...NASDAQ:REGNRegeneron Pharmaceuticals Inc
18/09/202017:05PR Newswire (US)Positive Pivotal Data for Libtayo® (cemiplimab) Monotherapy in Locally Advanced Basal Cell Carcinoma Featured as a Late-brea...NASDAQ:REGNRegeneron Pharmaceuticals Inc
16/09/202000:15PR Newswire (US)S&P 500 Buybacks Decline 55.4% to $88.7 Billion; Significant Reductions Expected to continue in Q3 2020NASDAQ:REGNRegeneron Pharmaceuticals Inc
14/09/202023:30GlobeNewswire Inc.Imanis Life Sciences to Present IMMUNO-COV, a First-in-Class Neutralizing Antibody Test for COVID-19, at American Society of ...NASDAQ:REGNRegeneron Pharmaceuticals Inc
14/09/202021:00PR Newswire (US)RECOVERY COVID-19 Phase 3 Trial to Evaluate Regeneron's REGN-COV2 Investigational Antibody Cocktail in the UKNASDAQ:REGNRegeneron Pharmaceuticals Inc
14/09/202014:59PR Newswire (US)FDA Grants Dupixent® (dupilumab) Breakthrough Therapy Designation for Eosinophilic EsophagitisNASDAQ:REGNRegeneron Pharmaceuticals Inc
08/09/202014:59PR Newswire (US)Dupixent® (dupilumab) Long-term Data Show Sustained Improvement in Lung Function and Reduction in Severe Exacerbations in Ad...NASDAQ:REGNRegeneron Pharmaceuticals Inc
04/09/202006:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
03/09/202021:00PR Newswire (US)Late-breaking Libtayo® (cemiplimab) pivotal data in advanced non-small cell lung cancer and basal cell carcinoma to be prese...NASDAQ:REGNRegeneron Pharmaceuticals Inc
03/09/202020:59PR Newswire (US)Late-breaking Libtayo® (cemiplimab) Pivotal Data in Advanced Non-small Cell Lung Cancer and Basal Cell Carcinoma to Be Prese...NASDAQ:REGNRegeneron Pharmaceuticals Inc
01/09/202015:52Dow Jones NewsSanofi's Kevzara Phase 3 Trial for Covid-19 Failed to Meet Primary EndpointNASDAQ:REGNRegeneron Pharmaceuticals Inc
01/09/202006:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
01/09/202006:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
28/08/202006:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
28/08/202006:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
26/08/202021:00PR Newswire (US)Regeneron Announces Investor Conference PresentationsNASDAQ:REGNRegeneron Pharmaceuticals Inc
25/08/202008:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
25/08/202008:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
25/08/202007:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
25/08/202006:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
24/08/202003:34Dow Jones NewsCorrection to Antibody Drugs for Covid-19 Treatment ArticleNASDAQ:REGNRegeneron Pharmaceuticals Inc
23/08/202019:59Dow Jones NewsAntibody Drugs Advancing to Fill Covid-19 Treatment GapNASDAQ:REGNRegeneron Pharmaceuticals Inc
20/08/202007:01PR Newswire (US)New England Journal of Medicine Publishes Positive Phase 3 Evinacumab Results in Patients with Severe Inherited Form of High ...NASDAQ:REGNRegeneron Pharmaceuticals Inc
19/08/202015:29Dow Jones NewsRegeneron Enlists Swiss Rival Roche to Help Make Covid-19 DrugNASDAQ:REGNRegeneron Pharmaceuticals Inc
19/08/202015:00PR Newswire (US)Regeneron and Roche Collaborate to Significantly Increase Global Supply of REGN-COV2 Investigational Antibody Cocktail for CO...NASDAQ:REGNRegeneron Pharmaceuticals Inc
13/08/202006:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REGNRegeneron Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:REGN